In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the evolution, research and pearls for ablation procedures, and emerging considerations for histotripsy in the realm of interventional oncology.
|Articles|September 2, 1998
Yamanouchi to develop ImaRx agent
Japanese drug firm Yamanouchi Pharmaceutical has begun clinical development in Japan of YM454, the company's version of an ultrasound contrast agent licensed from ImaRx Pharmaceutical of Tucson. Yamanouchi has Asian marketing rights for the agent, which
Advertisement
Japanese drug firm Yamanouchi Pharmaceutical has begun clinical development in Japan of YM454, the company's version of an ultrasound contrast agent licensed from ImaRx Pharmaceutical of Tucson. Yamanouchi has Asian marketing rights for the agent, which ImaRx is co-developing in the U.S. with Du Pont Pharmaceutical under the name DMP115.
Advertisement
Related to this article
New research found that the late arterial phase, which accounts for approximately 40 percent of CT radiation dosing in cases involving acute abdominal pain, offered no exclusive findings that had an impact on clinical care.
New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.
Perspective and experience enable us to discern a reasonable explanation prior to boarding a rollercoaster of overreaction.
Catch up on the top radiology content of the past week.
Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI).
Catch up on the most-well viewed radiology content in October 2026.
In the second of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, discussed the possible impact of new research showing significant declines in CT radiation dosing over the past decade, future research directions and the potential for indication-based diagnostic reference levels (DRLs) in the future.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Key Features with EPNI on CT May More than Double Mortality Risk in Pancreatic Cancer
2
Is Late Arterial Phase CT Necessary for Undifferentiated Acute Abdominal Pain?
3
Could a CCTA-Guided Approach Provide a Viable Alternative to Intravascular Ultrasound Guidance for PCI Procedures?
4
Interventional Radiology in Focus: Emerging Concepts with Ablation and Histotripsy in Interventional Oncology
5